Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells.
Bozdag, M., Ferraroni, M., Ward, C., Carta, F., Bua, S., Angeli, A., Langdon, S.P., Kunkler, I.H., Al-Tamimi, A.S., Supuran, C.T.(2019) Eur J Med Chem 182: 111600-111600
- PubMed: 31419777 
- DOI: https://doi.org/10.1016/j.ejmech.2019.111600
- Primary Citation of Related Structures:  
6I0J, 6I0L - PubMed Abstract: 
Carbonic anhydrase inhibitors (CAIs) of the sulfonamide, sulfamate and coumarin classes bearing the phenylureido tail found in the clinically used drug Sorafenib, a multikinase inhibitor actually used for the management of hepatocellular carcinomas, are reported ...